ORTHOPEDICS AND TRAUMATOLOGY / EXPERIMENTAL RESEARCH
Metformin alleviates intervertebral disc degeneration by upregulating MMP-1 expression via the KDM6A/SOX9/miR-202-3p/MMP-1 signaling pathway
More details
Hide details
1
Ankang Hospital of Traditional Chinese Medicine, Ankang, Shaanxi Province, China
2
Yangling Demonstration Zone Hospital, Yangling, Shaanxi Province, China
3
The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan Province, China
Submission date: 2019-12-16
Final revision date: 2020-01-21
Acceptance date: 2020-01-25
Online publication date: 2021-03-25
Corresponding author
Zhi-hua Wang
The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan Province, China 650101
KEYWORDS
TOPICS
ABSTRACT
Introduction:
MiR-202-3p is involved in the pathogenesis of intervertebral disc degeneration (IDD) via regulating MMP-1 expression in neuronal precursor cells (NPCs). As an activator of miR-202-3p and KDM6A expression, metformin (MET) may regulate the expression of SOX9 via regulating the methylation status of the SOX9 promoter. However, the role of MET in the treatment of IDD remains to be explored.
Material and methods:
Quantitative real-time PCR was performed to analyze the expression of KDM66, SOX9, MMP-1 and miR-202-3p in NPCs and IDD rabbits. Western blot was carried out to evaluate the expression of KDM6A, SOX9 and MMP-1 protein under different conditions. Bisulfite sequencing PCR was used to analyze the DNA methylation of the SOX9 promoter. Luciferase assay was carried out to explore the inhibitory effect of miR-202-3p upon MMP-1.
Results:
The expression of KDM6A, SOX9 and MMP-1 was abnormal in IDD cells and rabbits, while the MET treatment restored the normal expression of KDM6A, SOX9 and MMP-1 and miR-202-3p. Mechanistically, MET treatment reduced the level of hypermethylation of the SOX9 promoter, thus restoring the expression of SOX9 in IDD cells and rabbits. The elevation in SOX9 expression promoted the expression of miR-202-3p, therefore inhibiting the expression of MMP-1, a downstream target of miR-202-3p.
Conclusions:
In this study, we set up cellular and animal models of IDD and treated them with MET to probe the effect of MET on IDD and the signaling pathway of KDM6A/SOX9/miR-202-3p/MMP-1. Our work provided deep insight into the molecular mechanism underlying the therapeutic role of MET in the treatment of IDD.
REFERENCES (31)
1.
Andersson GB. Epidemiological features of chronic low-back pain. Lancet 1999; 354: 581-5.
2.
Waddell G. Low back pain: a twentieth century health care enigma. Spine (Phila Pa 1976) 1996; 21: 2820-5.
3.
Ma K, Chen S, Li Z, et al. Mechanisms of endogenous repair failure during intervertebral disc degeneration. Osteoarthritis Cartilage 2019; 27: 41-8.
4.
Kepler CK, Ponnappan RK, Tannoury CA, Risbud MV, Anderson DG. The molecular basis of intervertebral disc degeneration. Spine J 2013; 13: 318-30.
5.
Shek AB, Alieva RB, Kurbanov RD, Hoshimov SU, Nizamov UI, Ziyaeva AV. Can metformin stabilize PCSK9 level in stable coronary artery disease patients treated with statins? Arch Med Sci Atheroscler Dis 2019; 4: e144-50.
6.
Deng B, Ren JZ, Meng XQ, et al. Expression profiles of MMP-1 and TIMP-1 in lumbar intervertebral disc degeneration. Genet Mol Res 2015; 14: 19080-6.
7.
Baillet A, Grange L, Trocme C, et al. Differences in MMPs and TIMP-1 expression between intervertebral disc and disc herniation. Joint Bone Spine 2013; 80: 341-2.
8.
Xu H, Mei Q, He J, Liu G, Zhao J, Xu B. Correlation of matrix metalloproteinases-1 and tissue inhibitor of metalloproteinases-1 with patient age and grade of lumbar disk herniation. Cell Biochem Biophys 2014; 69: 439-44.
9.
Kim J, Kang Y, Kojima Y, et al. An endothelial apelin-FGF link mediated by miR-424 and miR-503 is disrupted in pulmonary arterial hypertension. Nat Med 2013; 19: 74-82.
10.
Vaira V, Faversani A, Dohi T, et al. miR-296 regulation of a cell polarity-cell plasticity module controls tumor progression. Oncogene 2012; 31: 27-38.
11.
Catuogno S, Cerchia L, Romano G, Pognonec P, Condorelli G, de Franciscis V. miR-34c may protect lung cancer cells from paclitaxel-induced apoptosis. Oncogene 2013; 32: 341-51.
12.
Chuang JC, Jones PA. Epigenetics and microRNAs. Pediatr Res 2007; 61: 24R-9R.
13.
Jansson MD, Lund AH. MicroRNA and cancer. Mol Oncol 2012; 6: 590-610.
14.
Yu X, Li Z, Shen J, et al. MicroRNA-10b promotes nucleus pulposus cell proliferation through RhoC-Akt pathway by targeting HOXD10 in intervetebral disc degeneration. PLoS One 2013; 8: e83080.
15.
Cuyas E, Verdura S, Llorach-Pares L, et al. Metformin directly targets the H3K27me3 demethylase KDM6A/UTX. Aging Cell 2018; 17: e12772.
16.
Shi C, Wu L, Lin W, et al. MiR-202-3p regulates interleukin-1beta-induced expression of matrix metalloproteinase 1 in human nucleus pulposus. Gene 2019; 687: 156-65.
17.
Wainwright EN, Jorgensen JS, Kim Y, et al. SOX9 regulates microRNA miR-202-5p/3p expression during mouse testis differentiation. Biol Reprod 2013; 89: 34.
18.
Hu B, Shi C, Xu C, et al. Heme oxygenase-1 attenuates IL-1beta induced alteration of anabolic and catabolic activities in intervertebral disc degeneration. Sci Rep 2016; 6: 21190.
19.
Shin-Young P, Min-Jeong K, Joong-Soo H. Interleukin-1 beta promotes neuronal differentiation through the Wnt5a/RhoA/JNK pathway in cortical neural precursor cells. Mol Brain 2018; 11: 39.
20.
Van der Meulen J, Speleman F, Van Vlierberghe P. The H3K27me3 demethylase UTX in normal development and disease. Epigenetics 2014; 9: 658-68.
21.
Hemming S, Cakouros D, Isenmann S, et al. EZH2 and KDM6A act as an epigenetic switch to regulate mesenchymal stem cell lineage specification. Stem Cells 2014; 32: 802-15.
22.
Wagner T, Wirth J, Meyer J, et al. Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9. Cell 1994; 79: 1111-20.
23.
Chaboissier MC, Kobayashi A, Vidal VI, et al. Functional analysis of Sox8 and Sox9 during sex determination in the mouse. Development 2004; 131: 1891-901.
24.
Vidal VP, Chaboissier MC, de Rooij DG, Schedl A. SOX9 induces testis development in XX transgenic mice. Nat Genet 2001; 28: 216-7.
25.
Arango NA, Lovell-Badge R, Behringer RR. Targeted mutagenesis of the endogenous mouse Mis gene promoter: in vivo definition of genetic pathways of vertebrate sexual development. Cell 1999; 99: 409-19.
26.
Nakamura Y, Yamamoto K, He X, et al. Wwp2 is essential for palatogenesis mediated by the interaction between Sox9 and mediator subunit 25. Nat Commun 2011; 2: 251.
27.
Yamashita S, Miyaki S, Kato Y, et al. L-Sox5 and Sox6 proteins enhance chondrogenic miR-140 microRNA expression by strengthening dimeric Sox9 activity. J Biol Chem 2012; 287: 22206-15.
28.
Vo NV, Hartman RA, Yurube T, Jacobs LJ, Sowa GA, Kang JD. Expression and regulation of metalloproteinases and their inhibitors in intervertebral disc aging and degeneration. Spine J 2013; 13: 331-41.
29.
Vincenti MP, Brinckerhoff CE. Transcriptional regulation of collagenase (MMP-1, MMP-13) genes in arthritis: integration of complex signaling pathways for the recruitment of gene-specific transcription factors. Arthritis Res 2002; 4: 157-64.
30.
Basaran R, Senol M, Ozkanli S, Efendioglu M, Kaner T. Correlation of matrix metalloproteinase (MMP)-1, -2, -3, and -9 expressions with demographic and radiological features in primary lumbar intervertebral disc disease. J Clin Neurosci 2017; 41: 46-9.
31.
Zigouris A, Batistatou A, Alexiou GA, et al. Correlation of matrix metalloproteinases-1 and -3 with patient age and grade of lumbar disc herniation. J Neurosurg Spine 2011; 14: 268-72.